Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (187)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,544
Price
$544.65
Total Value
$840.94K
Shares Held After
42,616
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,721
Price
$543.68
Total Value
$935.67K
Shares Held After
44,160
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,833
Price
$542.66
Total Value
$994.69K
Shares Held After
45,881
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,699
Price
$541.75
Total Value
$920.43K
Shares Held After
47,714
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$540.51
Total Value
$237.83K
Shares Held After
49,413
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$538.73
Total Value
$21.55K
Shares Held After
49,853
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$536.97
Total Value
$64.44K
Shares Held After
49,893
% of Holdings
0.2%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
54,641
Price
$101.00
Total Value
$5.52M
Shares Held After
524,938
% of Holdings
9.4%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
24,727
Price
$80.26
Total Value
$1.98M
Shares Held After
61,202
% of Holdings
28.8%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
517
Price
$53.59
Total Value
$27.71K
Shares Held After
66,280
% of Holdings
0.8%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
6,523
Price
$52.88
Total Value
$344.92K
Shares Held After
66,797
% of Holdings
8.9%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
600
Price
$1.24
Total Value
$744.00
Shares Held After
274,466
% of Holdings
0.2%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.70
Total Value
$261.12K
Shares Held After
477,568
% of Holdings
3.8%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Soteropoulos Paula — Director
Shares
27,594
Price
$78.05
Total Value
$2.15M
Shares Held After
0
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,492
Price
$5.78
Total Value
$31.74K
Shares Held After
544,508
% of Holdings
1.0%
GENELUX Corp (GNLX)
Cappello Joseph — Chief Technical Officer
Shares
906
Price
$2.42
Total Value
$2.19K
Shares Held After
155,154
% of Holdings
0.6%
GENELUX Corp (GNLX)
Smalling Ralph — Head of Regulatory
Shares
345
Price
$2.42
Total Value
$834.90
Shares Held After
68,313
% of Holdings
0.5%
GENELUX Corp (GNLX)
Yu Yong — SVP, Clinical Development
Shares
906
Price
$2.42
Total Value
$2.19K
Shares Held After
144,938
% of Holdings
0.6%
GENELUX Corp (GNLX)
Zindrick Thomas — President and CEO
Shares
3,582
Price
$2.42
Total Value
$8.67K
Shares Held After
534,849
% of Holdings
0.7%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
1,160
Price
$96.50
Total Value
$111.94K
Shares Held After
99,233
% of Holdings
1.2%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
7,671
Price
$95.88
Total Value
$735.50K
Shares Held After
100,393
% of Holdings
7.1%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
2,599
Price
$95.03
Total Value
$246.98K
Shares Held After
108,064
% of Holdings
2.3%
GLAUKOS Corp (GKOS)
Thurman Alex R. — SVP & CHIEF FINANCIAL OFFICER
Shares
1,521
Price
$105.24
Total Value
$160.07K
Shares Held After
46,498
% of Holdings
3.2%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
59
Price
$101.00
Total Value
$5.96K
Shares Held After
524,938
% of Holdings
0.0%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
53,329
Price
$24.69
Total Value
$1.32M
Shares Held After
736,547
% of Holdings
7.2%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
53,329
Price
$24.69
Total Value
$1.32M
Shares Held After
736,554
% of Holdings
7.2%
10x Genomics, Inc. (TXG)
Saxonov Serge — Director
Shares
5,000
Price
$19.52
Total Value
$97.61K
Shares Held After
1,172,273
% of Holdings
0.4%
Tempest Therapeutics, Inc. (TPST)
Angel Matthew — Director
Shares
231,482
Price
$2.16
Total Value
$500.00K
Shares Held After
231,482
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$536.02
Total Value
$42.88K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
536
Price
$535.39
Total Value
$286.97K
Shares Held After
40,593
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
709
Price
$534.31
Total Value
$378.83K
Shares Held After
41,129
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,890
Price
$533.21
Total Value
$1.01M
Shares Held After
41,838
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,605
Price
$532.24
Total Value
$854.24K
Shares Held After
43,728
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$530.73
Total Value
$254.75K
Shares Held After
45,333
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$529.48
Total Value
$148.26K
Shares Held After
45,813
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$528.02
Total Value
$211.21K
Shares Held After
46,093
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$526.94
Total Value
$358.32K
Shares Held After
46,493
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$525.93
Total Value
$252.45K
Shares Held After
47,173
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
256
Price
$524.62
Total Value
$134.30K
Shares Held After
47,653
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
737
Price
$523.93
Total Value
$386.13K
Shares Held After
47,909
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
527
Price
$522.89
Total Value
$275.56K
Shares Held After
48,646
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$521.85
Total Value
$208.74K
Shares Held After
49,173
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$520.75
Total Value
$62.49K
Shares Held After
49,573
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$519.10
Total Value
$145.35K
Shares Held After
49,693
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$516.84
Total Value
$20.67K
Shares Held After
49,973
% of Holdings
0.1%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
915
Price
$100.71
Total Value
$92.15K
Shares Held After
2,232,500
% of Holdings
0.0%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
1,585
Price
$100.03
Total Value
$158.55K
Shares Held After
2,233,415
% of Holdings
0.1%
MeiraGTx Holdings plc (MGTX)
Forbes Alexandria — Director
Shares
62,000
Price
$7.41
Total Value
$459.42K
Shares Held After
1,449,695
% of Holdings
4.1%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
5,000
Price
$72.00
Total Value
$360.00K
Shares Held After
15,000
% of Holdings
33.3%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
34,665
Price
$72.00
Total Value
$2.50M
Shares Held After
485,000
% of Holdings
7.1%
Showing 101–150 of 187 transactions (page 3 of 4)